IMV Inc. re-establishes At-The-Market facility
October 16, 2020
50.00 Million USD
On October 16, 2020 IMV Inc. announced that it has entered into an equity distribution agreement with Piper Sandler & Co. Under this agreement, Piper Sandler will act as agent and IMV may sell its common shares through at-the-market offerings for an aggregate offering price of US$50 million.
IMV, a clinical-stage biopharmaceutical company, will use the funds raised by this offering for general corporate purposes, including but not limited to working capital expenditures, capital expenditures, research and development expenditures, COVID-19 vaccine candidate expenditures, and clinical trial expenditures.
McCarthy Tétrault acted as Canadian counsel to IMV with a team led by Philippe Leclerc and included Myreille Gilbert and Annie Poirier-Simard.